BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2854322)

  • 1. A bi-functional reporter plasmid for the simultaneous transient expression assay of two herpes simplex virus promoters.
    Flanagan WM; Wagner EK
    Virus Genes; 1987 Nov; 1(1):61-71. PubMed ID: 2854322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation with concurrent or nonconcurrent template replication has differential effects on transient expression from herpes simplex virus promoters.
    Snowden BW; Blair ED; Wagner EK
    Virus Genes; 1989 Mar; 2(2):129-45. PubMed ID: 2541559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1.
    Chen JX; Zhu XX; Silverstein S
    Virology; 1991 Jan; 180(1):207-20. PubMed ID: 1845823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High efficiency transient expression of eukaryotic genes: use of an HSV-1 immediate early promoter (ICP4).
    Liu X; Giza CC; Vrana KE
    Biotechniques; 1990 Aug; 9(2):168-73. PubMed ID: 2169263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.
    Mohan RR; Schultz GS; Hong JW; Mohan RR; Wilson SE
    Exp Eye Res; 2003 Mar; 76(3):373-83. PubMed ID: 12573666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5).
    Costa RH; Draper KG; Devi-Rao G; Thompson RL; Wagner EK
    J Virol; 1985 Oct; 56(1):19-30. PubMed ID: 2993649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters].
    Loparev VN; Chernos VI
    Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter.
    Huang CJ; Goodart SA; Rice MK; Guzowski JF; Wagner EK
    J Virol; 1993 Sep; 67(9):5109-16. PubMed ID: 8394439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genomic location on expression of beta-galactosidase mRNA controlled by the herpes simplex virus type 1 UL38 promoter.
    Goodart SA; Guzowski JF; Rice MK; Wagner EK
    J Virol; 1992 May; 66(5):2973-81. PubMed ID: 1313912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 alpha gene containing plasmids can inhibit expression regulated from an alpha promoter in CV-1 but not HeLa cells.
    Block T; Jordan R
    Virus Res; 1988 Nov; 11(4):269-79. PubMed ID: 2851895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus infection selectively stimulates accumulation of beta interferon reporter gene mRNA by a posttranscriptional mechanism.
    Mosca JD; Pitha PM; Hayward GS
    J Virol; 1992 Jun; 66(6):3811-22. PubMed ID: 1316484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses.
    Weir JP; Narayanan PR
    Nucleic Acids Res; 1988 Nov; 16(21):10267-82. PubMed ID: 2848220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transient gene expression with plasmids encoding herpes simplex virus type 1 UL55 and alpha genes.
    Block T; Jordan R; Farkas DH; Hughes RG
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():131-41. PubMed ID: 1846642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus thymidine kinase enzymatic assay in transient transfection experiments using thymidine kinase-deficient cells.
    Jonsson JJ; McIvor RS
    Anal Biochem; 1991 Dec; 199(2):232-7. PubMed ID: 1667455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.
    Geller AI
    J Neurosci Methods; 1991 Jan; 36(1):91-103. PubMed ID: 1648153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase.
    Lim K; Chae CB
    Biotechniques; 1989 Jun; 7(6):576-9. PubMed ID: 2517211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of DNA sequences at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type 1.
    Rixon FJ; McLauchlan J
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2931-9. PubMed ID: 2177085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAT vectors for analysis of eukaryotic promoters and enhancers.
    Prost E; Moore DD
    Gene; 1986; 45(1):107-11. PubMed ID: 3023200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans.
    Everett RD
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2507-13. PubMed ID: 3023536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.
    Geller AI; Breakefield XO
    Science; 1988 Sep; 241(4873):1667-9. PubMed ID: 2843986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.